nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP3A4—bone cancer	0.627	1	CbGaD
Paliperidone—HTR1B—dura mater—bone cancer	0.0194	0.203	CbGeAlD
Paliperidone—HTR1D—dura mater—bone cancer	0.0188	0.197	CbGeAlD
Paliperidone—HTR1B—trigeminal nerve—bone cancer	0.00835	0.0875	CbGeAlD
Paliperidone—HTR1D—trigeminal nerve—bone cancer	0.00808	0.0847	CbGeAlD
Paliperidone—HRH1—nose—bone cancer	0.00613	0.0642	CbGeAlD
Paliperidone—HTR1B—cranial nerve—bone cancer	0.00595	0.0623	CbGeAlD
Paliperidone—HTR1D—cranial nerve—bone cancer	0.00576	0.0603	CbGeAlD
Paliperidone—HTR2A—trigeminal nerve—bone cancer	0.00402	0.0421	CbGeAlD
Paliperidone—HTR2A—cranial nerve—bone cancer	0.00286	0.03	CbGeAlD
Paliperidone—HTR2A—vertebral column—bone cancer	0.00281	0.0294	CbGeAlD
Paliperidone—HTR2A—hindlimb—bone cancer	0.00241	0.0253	CbGeAlD
Paliperidone—HTR2A—appendage—bone cancer	0.00207	0.0217	CbGeAlD
Paliperidone—Risperidone—CYP3A4—bone cancer	0.00189	0.516	CrCbGaD
Paliperidone—Iloperidone—CYP3A4—bone cancer	0.00177	0.484	CrCbGaD
Paliperidone—HTR1D—connective tissue—bone cancer	0.00119	0.0124	CbGeAlD
Paliperidone—HTR1B—spinal cord—bone cancer	0.000814	0.00852	CbGeAlD
Paliperidone—HTR2C—spinal cord—bone cancer	0.00078	0.00817	CbGeAlD
Paliperidone—HRH1—connective tissue—bone cancer	0.000707	0.0074	CbGeAlD
Paliperidone—ADRA2A—connective tissue—bone cancer	0.000694	0.00727	CbGeAlD
Paliperidone—HTR1A—spinal cord—bone cancer	0.000657	0.00688	CbGeAlD
Paliperidone—ADRA2C—tendon—bone cancer	0.000598	0.00627	CbGeAlD
Paliperidone—HTR2A—connective tissue—bone cancer	0.00059	0.00618	CbGeAlD
Paliperidone—ADRA2C—spinal cord—bone cancer	0.000577	0.00604	CbGeAlD
Paliperidone—HRH1—tendon—bone cancer	0.000486	0.00509	CbGeAlD
Paliperidone—ADRA2A—tendon—bone cancer	0.000477	0.005	CbGeAlD
Paliperidone—ADRA2A—spinal cord—bone cancer	0.00046	0.00482	CbGeAlD
Paliperidone—HTR2A—tendon—bone cancer	0.000406	0.00425	CbGeAlD
Paliperidone—HTR2A—spinal cord—bone cancer	0.000391	0.0041	CbGeAlD
Paliperidone—Pollakiuria—Doxorubicin—bone cancer	0.000298	0.00141	CcSEcCtD
Paliperidone—Urinary tract disorder—Methotrexate—bone cancer	0.000295	0.0014	CcSEcCtD
Paliperidone—Hepatobiliary disease—Epirubicin—bone cancer	0.000294	0.00139	CcSEcCtD
Paliperidone—Weight increased—Doxorubicin—bone cancer	0.000294	0.00139	CcSEcCtD
Paliperidone—Epistaxis—Epirubicin—bone cancer	0.000293	0.00139	CcSEcCtD
Paliperidone—Urethral disorder—Methotrexate—bone cancer	0.000292	0.00139	CcSEcCtD
Paliperidone—Weight decreased—Doxorubicin—bone cancer	0.000292	0.00138	CcSEcCtD
Paliperidone—Sinusitis—Epirubicin—bone cancer	0.000292	0.00138	CcSEcCtD
Paliperidone—Hyperglycaemia—Doxorubicin—bone cancer	0.000291	0.00138	CcSEcCtD
Paliperidone—Agranulocytosis—Epirubicin—bone cancer	0.00029	0.00138	CcSEcCtD
Paliperidone—Pneumonia—Doxorubicin—bone cancer	0.000289	0.00137	CcSEcCtD
Paliperidone—Infestation—Doxorubicin—bone cancer	0.000288	0.00136	CcSEcCtD
Paliperidone—Infestation NOS—Doxorubicin—bone cancer	0.000288	0.00136	CcSEcCtD
Paliperidone—Hypersensitivity—Cisplatin—bone cancer	0.000284	0.00135	CcSEcCtD
Paliperidone—Bradycardia—Epirubicin—bone cancer	0.000284	0.00135	CcSEcCtD
Paliperidone—Jaundice—Doxorubicin—bone cancer	0.00028	0.00133	CcSEcCtD
Paliperidone—Rhinitis—Epirubicin—bone cancer	0.00028	0.00133	CcSEcCtD
Paliperidone—Conjunctivitis—Doxorubicin—bone cancer	0.00028	0.00133	CcSEcCtD
Paliperidone—Urinary tract infection—Doxorubicin—bone cancer	0.00028	0.00133	CcSEcCtD
Paliperidone—Eye disorder—Methotrexate—bone cancer	0.000279	0.00132	CcSEcCtD
Paliperidone—Tinnitus—Methotrexate—bone cancer	0.000278	0.00132	CcSEcCtD
Paliperidone—Hypoaesthesia—Epirubicin—bone cancer	0.000278	0.00132	CcSEcCtD
Paliperidone—Asthenia—Cisplatin—bone cancer	0.000277	0.00131	CcSEcCtD
Paliperidone—Cardiac disorder—Methotrexate—bone cancer	0.000277	0.00131	CcSEcCtD
Paliperidone—Urinary tract disorder—Epirubicin—bone cancer	0.000276	0.00131	CcSEcCtD
Paliperidone—Oedema peripheral—Epirubicin—bone cancer	0.000275	0.0013	CcSEcCtD
Paliperidone—Connective tissue disorder—Epirubicin—bone cancer	0.000274	0.0013	CcSEcCtD
Paliperidone—Urethral disorder—Epirubicin—bone cancer	0.000274	0.0013	CcSEcCtD
Paliperidone—Hepatobiliary disease—Doxorubicin—bone cancer	0.000272	0.00129	CcSEcCtD
Paliperidone—Epistaxis—Doxorubicin—bone cancer	0.000271	0.00129	CcSEcCtD
Paliperidone—Angiopathy—Methotrexate—bone cancer	0.000271	0.00128	CcSEcCtD
Paliperidone—Sinusitis—Doxorubicin—bone cancer	0.00027	0.00128	CcSEcCtD
Paliperidone—Immune system disorder—Methotrexate—bone cancer	0.000269	0.00128	CcSEcCtD
Paliperidone—Mediastinal disorder—Methotrexate—bone cancer	0.000269	0.00127	CcSEcCtD
Paliperidone—Agranulocytosis—Doxorubicin—bone cancer	0.000268	0.00127	CcSEcCtD
Paliperidone—Chills—Methotrexate—bone cancer	0.000268	0.00127	CcSEcCtD
Paliperidone—Diarrhoea—Cisplatin—bone cancer	0.000264	0.00125	CcSEcCtD
Paliperidone—Alopecia—Methotrexate—bone cancer	0.000264	0.00125	CcSEcCtD
Paliperidone—Bradycardia—Doxorubicin—bone cancer	0.000263	0.00125	CcSEcCtD
Paliperidone—Mental disorder—Methotrexate—bone cancer	0.000261	0.00124	CcSEcCtD
Paliperidone—Eye disorder—Epirubicin—bone cancer	0.000261	0.00124	CcSEcCtD
Paliperidone—Tinnitus—Epirubicin—bone cancer	0.00026	0.00123	CcSEcCtD
Paliperidone—Malnutrition—Methotrexate—bone cancer	0.00026	0.00123	CcSEcCtD
Paliperidone—Erythema—Methotrexate—bone cancer	0.00026	0.00123	CcSEcCtD
Paliperidone—Cardiac disorder—Epirubicin—bone cancer	0.000259	0.00123	CcSEcCtD
Paliperidone—Flushing—Epirubicin—bone cancer	0.000259	0.00123	CcSEcCtD
Paliperidone—Rhinitis—Doxorubicin—bone cancer	0.000259	0.00123	CcSEcCtD
Paliperidone—Hypoaesthesia—Doxorubicin—bone cancer	0.000257	0.00122	CcSEcCtD
Paliperidone—Urinary tract disorder—Doxorubicin—bone cancer	0.000255	0.00121	CcSEcCtD
Paliperidone—Oedema peripheral—Doxorubicin—bone cancer	0.000254	0.00121	CcSEcCtD
Paliperidone—Dysgeusia—Methotrexate—bone cancer	0.000254	0.00121	CcSEcCtD
Paliperidone—Connective tissue disorder—Doxorubicin—bone cancer	0.000254	0.0012	CcSEcCtD
Paliperidone—Angiopathy—Epirubicin—bone cancer	0.000253	0.0012	CcSEcCtD
Paliperidone—Urethral disorder—Doxorubicin—bone cancer	0.000253	0.0012	CcSEcCtD
Paliperidone—Immune system disorder—Epirubicin—bone cancer	0.000252	0.00119	CcSEcCtD
Paliperidone—Mediastinal disorder—Epirubicin—bone cancer	0.000252	0.00119	CcSEcCtD
Paliperidone—Back pain—Methotrexate—bone cancer	0.000251	0.00119	CcSEcCtD
Paliperidone—Chills—Epirubicin—bone cancer	0.00025	0.00119	CcSEcCtD
Paliperidone—Alopecia—Epirubicin—bone cancer	0.000247	0.00117	CcSEcCtD
Paliperidone—Vomiting—Cisplatin—bone cancer	0.000246	0.00116	CcSEcCtD
Paliperidone—Vision blurred—Methotrexate—bone cancer	0.000245	0.00116	CcSEcCtD
Paliperidone—Mental disorder—Epirubicin—bone cancer	0.000245	0.00116	CcSEcCtD
Paliperidone—Rash—Cisplatin—bone cancer	0.000243	0.00115	CcSEcCtD
Paliperidone—Dermatitis—Cisplatin—bone cancer	0.000243	0.00115	CcSEcCtD
Paliperidone—Erythema—Epirubicin—bone cancer	0.000243	0.00115	CcSEcCtD
Paliperidone—Malnutrition—Epirubicin—bone cancer	0.000243	0.00115	CcSEcCtD
Paliperidone—Eye disorder—Doxorubicin—bone cancer	0.000241	0.00114	CcSEcCtD
Paliperidone—Ill-defined disorder—Methotrexate—bone cancer	0.000241	0.00114	CcSEcCtD
Paliperidone—Tinnitus—Doxorubicin—bone cancer	0.000241	0.00114	CcSEcCtD
Paliperidone—Anaemia—Methotrexate—bone cancer	0.00024	0.00114	CcSEcCtD
Paliperidone—Flushing—Doxorubicin—bone cancer	0.00024	0.00114	CcSEcCtD
Paliperidone—Cardiac disorder—Doxorubicin—bone cancer	0.00024	0.00114	CcSEcCtD
Paliperidone—Flatulence—Epirubicin—bone cancer	0.000239	0.00113	CcSEcCtD
Paliperidone—Tension—Epirubicin—bone cancer	0.000238	0.00113	CcSEcCtD
Paliperidone—Dysgeusia—Epirubicin—bone cancer	0.000238	0.00113	CcSEcCtD
Paliperidone—Nervousness—Epirubicin—bone cancer	0.000236	0.00112	CcSEcCtD
Paliperidone—Back pain—Epirubicin—bone cancer	0.000235	0.00111	CcSEcCtD
Paliperidone—Angiopathy—Doxorubicin—bone cancer	0.000234	0.00111	CcSEcCtD
Paliperidone—Malaise—Methotrexate—bone cancer	0.000234	0.00111	CcSEcCtD
Paliperidone—Muscle spasms—Epirubicin—bone cancer	0.000234	0.00111	CcSEcCtD
Paliperidone—Immune system disorder—Doxorubicin—bone cancer	0.000233	0.00111	CcSEcCtD
Paliperidone—Vertigo—Methotrexate—bone cancer	0.000233	0.00111	CcSEcCtD
Paliperidone—Mediastinal disorder—Doxorubicin—bone cancer	0.000233	0.0011	CcSEcCtD
Paliperidone—Leukopenia—Methotrexate—bone cancer	0.000232	0.0011	CcSEcCtD
Paliperidone—Chills—Doxorubicin—bone cancer	0.000232	0.0011	CcSEcCtD
Paliperidone—Nausea—Cisplatin—bone cancer	0.000229	0.00109	CcSEcCtD
Paliperidone—Vision blurred—Epirubicin—bone cancer	0.000229	0.00109	CcSEcCtD
Paliperidone—Alopecia—Doxorubicin—bone cancer	0.000228	0.00108	CcSEcCtD
Paliperidone—Cough—Methotrexate—bone cancer	0.000227	0.00107	CcSEcCtD
Paliperidone—Mental disorder—Doxorubicin—bone cancer	0.000226	0.00107	CcSEcCtD
Paliperidone—Ill-defined disorder—Epirubicin—bone cancer	0.000225	0.00107	CcSEcCtD
Paliperidone—Convulsion—Methotrexate—bone cancer	0.000225	0.00107	CcSEcCtD
Paliperidone—Malnutrition—Doxorubicin—bone cancer	0.000225	0.00107	CcSEcCtD
Paliperidone—Erythema—Doxorubicin—bone cancer	0.000225	0.00107	CcSEcCtD
Paliperidone—Anaemia—Epirubicin—bone cancer	0.000225	0.00106	CcSEcCtD
Paliperidone—Agitation—Epirubicin—bone cancer	0.000223	0.00106	CcSEcCtD
Paliperidone—Flatulence—Doxorubicin—bone cancer	0.000222	0.00105	CcSEcCtD
Paliperidone—Myalgia—Methotrexate—bone cancer	0.000221	0.00105	CcSEcCtD
Paliperidone—Chest pain—Methotrexate—bone cancer	0.000221	0.00105	CcSEcCtD
Paliperidone—Arthralgia—Methotrexate—bone cancer	0.000221	0.00105	CcSEcCtD
Paliperidone—Tension—Doxorubicin—bone cancer	0.000221	0.00105	CcSEcCtD
Paliperidone—Dysgeusia—Doxorubicin—bone cancer	0.00022	0.00104	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00022	0.00104	CcSEcCtD
Paliperidone—Malaise—Epirubicin—bone cancer	0.000219	0.00104	CcSEcCtD
Paliperidone—Discomfort—Methotrexate—bone cancer	0.000218	0.00104	CcSEcCtD
Paliperidone—Nervousness—Doxorubicin—bone cancer	0.000218	0.00103	CcSEcCtD
Paliperidone—Vertigo—Epirubicin—bone cancer	0.000218	0.00103	CcSEcCtD
Paliperidone—Syncope—Epirubicin—bone cancer	0.000218	0.00103	CcSEcCtD
Paliperidone—Leukopenia—Epirubicin—bone cancer	0.000217	0.00103	CcSEcCtD
Paliperidone—Back pain—Doxorubicin—bone cancer	0.000217	0.00103	CcSEcCtD
Paliperidone—Muscle spasms—Doxorubicin—bone cancer	0.000216	0.00102	CcSEcCtD
Paliperidone—Palpitations—Epirubicin—bone cancer	0.000215	0.00102	CcSEcCtD
Paliperidone—Confusional state—Methotrexate—bone cancer	0.000214	0.00101	CcSEcCtD
Paliperidone—Loss of consciousness—Epirubicin—bone cancer	0.000214	0.00101	CcSEcCtD
Paliperidone—Cough—Epirubicin—bone cancer	0.000212	0.001	CcSEcCtD
Paliperidone—Anaphylactic shock—Methotrexate—bone cancer	0.000212	0.001	CcSEcCtD
Paliperidone—Vision blurred—Doxorubicin—bone cancer	0.000212	0.001	CcSEcCtD
Paliperidone—Convulsion—Epirubicin—bone cancer	0.000211	0.000998	CcSEcCtD
Paliperidone—Infection—Methotrexate—bone cancer	0.000211	0.000998	CcSEcCtD
Paliperidone—Hypertension—Epirubicin—bone cancer	0.00021	0.000994	CcSEcCtD
Paliperidone—Ill-defined disorder—Doxorubicin—bone cancer	0.000209	0.000989	CcSEcCtD
Paliperidone—Nervous system disorder—Methotrexate—bone cancer	0.000208	0.000985	CcSEcCtD
Paliperidone—Anaemia—Doxorubicin—bone cancer	0.000208	0.000985	CcSEcCtD
Paliperidone—Thrombocytopenia—Methotrexate—bone cancer	0.000207	0.000983	CcSEcCtD
Paliperidone—Arthralgia—Epirubicin—bone cancer	0.000207	0.00098	CcSEcCtD
Paliperidone—Chest pain—Epirubicin—bone cancer	0.000207	0.00098	CcSEcCtD
Paliperidone—Myalgia—Epirubicin—bone cancer	0.000207	0.00098	CcSEcCtD
Paliperidone—Agitation—Doxorubicin—bone cancer	0.000207	0.000979	CcSEcCtD
Paliperidone—Anxiety—Epirubicin—bone cancer	0.000206	0.000977	CcSEcCtD
Paliperidone—Skin disorder—Methotrexate—bone cancer	0.000206	0.000976	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000205	0.000974	CcSEcCtD
Paliperidone—Discomfort—Epirubicin—bone cancer	0.000204	0.000969	CcSEcCtD
Paliperidone—Malaise—Doxorubicin—bone cancer	0.000203	0.000961	CcSEcCtD
Paliperidone—Dry mouth—Epirubicin—bone cancer	0.000202	0.000959	CcSEcCtD
Paliperidone—Vertigo—Doxorubicin—bone cancer	0.000202	0.000957	CcSEcCtD
Paliperidone—Anorexia—Methotrexate—bone cancer	0.000202	0.000957	CcSEcCtD
Paliperidone—Syncope—Doxorubicin—bone cancer	0.000202	0.000956	CcSEcCtD
Paliperidone—Leukopenia—Doxorubicin—bone cancer	0.000201	0.000954	CcSEcCtD
Paliperidone—Confusional state—Epirubicin—bone cancer	0.0002	0.000948	CcSEcCtD
Paliperidone—Palpitations—Doxorubicin—bone cancer	0.000199	0.000942	CcSEcCtD
Paliperidone—Anaphylactic shock—Epirubicin—bone cancer	0.000198	0.00094	CcSEcCtD
Paliperidone—Oedema—Epirubicin—bone cancer	0.000198	0.00094	CcSEcCtD
Paliperidone—Hypotension—Methotrexate—bone cancer	0.000198	0.000939	CcSEcCtD
Paliperidone—Loss of consciousness—Doxorubicin—bone cancer	0.000198	0.000937	CcSEcCtD
Paliperidone—Infection—Epirubicin—bone cancer	0.000197	0.000934	CcSEcCtD
Paliperidone—Cough—Doxorubicin—bone cancer	0.000196	0.00093	CcSEcCtD
Paliperidone—Shock—Epirubicin—bone cancer	0.000195	0.000925	CcSEcCtD
Paliperidone—Convulsion—Doxorubicin—bone cancer	0.000195	0.000923	CcSEcCtD
Paliperidone—Nervous system disorder—Epirubicin—bone cancer	0.000194	0.000922	CcSEcCtD
Paliperidone—Thrombocytopenia—Epirubicin—bone cancer	0.000194	0.00092	CcSEcCtD
Paliperidone—Hypertension—Doxorubicin—bone cancer	0.000194	0.00092	CcSEcCtD
Paliperidone—Tachycardia—Epirubicin—bone cancer	0.000194	0.000917	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000193	0.000915	CcSEcCtD
Paliperidone—Skin disorder—Epirubicin—bone cancer	0.000193	0.000913	CcSEcCtD
Paliperidone—Insomnia—Methotrexate—bone cancer	0.000192	0.000908	CcSEcCtD
Paliperidone—Myalgia—Doxorubicin—bone cancer	0.000191	0.000907	CcSEcCtD
Paliperidone—Arthralgia—Doxorubicin—bone cancer	0.000191	0.000907	CcSEcCtD
Paliperidone—Chest pain—Doxorubicin—bone cancer	0.000191	0.000907	CcSEcCtD
Paliperidone—Anxiety—Doxorubicin—bone cancer	0.000191	0.000904	CcSEcCtD
Paliperidone—Paraesthesia—Methotrexate—bone cancer	0.00019	0.000902	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00019	0.000901	CcSEcCtD
Paliperidone—Discomfort—Doxorubicin—bone cancer	0.000189	0.000896	CcSEcCtD
Paliperidone—Anorexia—Epirubicin—bone cancer	0.000189	0.000896	CcSEcCtD
Paliperidone—Dyspnoea—Methotrexate—bone cancer	0.000189	0.000895	CcSEcCtD
Paliperidone—Somnolence—Methotrexate—bone cancer	0.000188	0.000893	CcSEcCtD
Paliperidone—Dry mouth—Doxorubicin—bone cancer	0.000187	0.000887	CcSEcCtD
Paliperidone—Dyspepsia—Methotrexate—bone cancer	0.000187	0.000884	CcSEcCtD
Paliperidone—Hypotension—Epirubicin—bone cancer	0.000185	0.000878	CcSEcCtD
Paliperidone—Confusional state—Doxorubicin—bone cancer	0.000185	0.000877	CcSEcCtD
Paliperidone—Decreased appetite—Methotrexate—bone cancer	0.000184	0.000873	CcSEcCtD
Paliperidone—Oedema—Doxorubicin—bone cancer	0.000183	0.00087	CcSEcCtD
Paliperidone—Anaphylactic shock—Doxorubicin—bone cancer	0.000183	0.00087	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000183	0.000867	CcSEcCtD
Paliperidone—Fatigue—Methotrexate—bone cancer	0.000183	0.000866	CcSEcCtD
Paliperidone—Infection—Doxorubicin—bone cancer	0.000182	0.000864	CcSEcCtD
Paliperidone—Pain—Methotrexate—bone cancer	0.000181	0.000859	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000181	0.000856	CcSEcCtD
Paliperidone—Shock—Doxorubicin—bone cancer	0.000181	0.000856	CcSEcCtD
Paliperidone—Nervous system disorder—Doxorubicin—bone cancer	0.00018	0.000853	CcSEcCtD
Paliperidone—Thrombocytopenia—Doxorubicin—bone cancer	0.00018	0.000852	CcSEcCtD
Paliperidone—Insomnia—Epirubicin—bone cancer	0.000179	0.00085	CcSEcCtD
Paliperidone—Tachycardia—Doxorubicin—bone cancer	0.000179	0.000849	CcSEcCtD
Paliperidone—Skin disorder—Doxorubicin—bone cancer	0.000178	0.000845	CcSEcCtD
Paliperidone—Paraesthesia—Epirubicin—bone cancer	0.000178	0.000844	CcSEcCtD
Paliperidone—Dyspnoea—Epirubicin—bone cancer	0.000177	0.000838	CcSEcCtD
Paliperidone—Somnolence—Epirubicin—bone cancer	0.000176	0.000836	CcSEcCtD
Paliperidone—Anorexia—Doxorubicin—bone cancer	0.000175	0.000829	CcSEcCtD
Paliperidone—Feeling abnormal—Methotrexate—bone cancer	0.000175	0.000828	CcSEcCtD
Paliperidone—Dyspepsia—Epirubicin—bone cancer	0.000175	0.000827	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methotrexate—bone cancer	0.000173	0.000821	CcSEcCtD
Paliperidone—Decreased appetite—Epirubicin—bone cancer	0.000172	0.000817	CcSEcCtD
Paliperidone—Hypotension—Doxorubicin—bone cancer	0.000171	0.000813	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000171	0.000811	CcSEcCtD
Paliperidone—Fatigue—Epirubicin—bone cancer	0.000171	0.00081	CcSEcCtD
Paliperidone—Pain—Epirubicin—bone cancer	0.00017	0.000804	CcSEcCtD
Paliperidone—Constipation—Epirubicin—bone cancer	0.00017	0.000804	CcSEcCtD
Paliperidone—Urticaria—Methotrexate—bone cancer	0.000168	0.000798	CcSEcCtD
Paliperidone—Abdominal pain—Methotrexate—bone cancer	0.000168	0.000794	CcSEcCtD
Paliperidone—Body temperature increased—Methotrexate—bone cancer	0.000168	0.000794	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000167	0.000792	CcSEcCtD
Paliperidone—Insomnia—Doxorubicin—bone cancer	0.000166	0.000787	CcSEcCtD
Paliperidone—Paraesthesia—Doxorubicin—bone cancer	0.000165	0.000781	CcSEcCtD
Paliperidone—Dyspnoea—Doxorubicin—bone cancer	0.000164	0.000775	CcSEcCtD
Paliperidone—Feeling abnormal—Epirubicin—bone cancer	0.000163	0.000775	CcSEcCtD
Paliperidone—Somnolence—Doxorubicin—bone cancer	0.000163	0.000773	CcSEcCtD
Paliperidone—Gastrointestinal pain—Epirubicin—bone cancer	0.000162	0.000769	CcSEcCtD
Paliperidone—Dyspepsia—Doxorubicin—bone cancer	0.000162	0.000766	CcSEcCtD
Paliperidone—Decreased appetite—Doxorubicin—bone cancer	0.000159	0.000756	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000158	0.000751	CcSEcCtD
Paliperidone—Fatigue—Doxorubicin—bone cancer	0.000158	0.00075	CcSEcCtD
Paliperidone—Urticaria—Epirubicin—bone cancer	0.000158	0.000747	CcSEcCtD
Paliperidone—Constipation—Doxorubicin—bone cancer	0.000157	0.000744	CcSEcCtD
Paliperidone—Pain—Doxorubicin—bone cancer	0.000157	0.000744	CcSEcCtD
Paliperidone—Abdominal pain—Epirubicin—bone cancer	0.000157	0.000743	CcSEcCtD
Paliperidone—Body temperature increased—Epirubicin—bone cancer	0.000157	0.000743	CcSEcCtD
Paliperidone—Hypersensitivity—Methotrexate—bone cancer	0.000156	0.00074	CcSEcCtD
Paliperidone—Asthenia—Methotrexate—bone cancer	0.000152	0.000721	CcSEcCtD
Paliperidone—Feeling abnormal—Doxorubicin—bone cancer	0.000151	0.000717	CcSEcCtD
Paliperidone—Gastrointestinal pain—Doxorubicin—bone cancer	0.00015	0.000711	CcSEcCtD
Paliperidone—Pruritus—Methotrexate—bone cancer	0.00015	0.000711	CcSEcCtD
Paliperidone—Hypersensitivity—Epirubicin—bone cancer	0.000146	0.000692	CcSEcCtD
Paliperidone—Urticaria—Doxorubicin—bone cancer	0.000146	0.000691	CcSEcCtD
Paliperidone—Body temperature increased—Doxorubicin—bone cancer	0.000145	0.000687	CcSEcCtD
Paliperidone—Abdominal pain—Doxorubicin—bone cancer	0.000145	0.000687	CcSEcCtD
Paliperidone—Diarrhoea—Methotrexate—bone cancer	0.000145	0.000687	CcSEcCtD
Paliperidone—Asthenia—Epirubicin—bone cancer	0.000142	0.000674	CcSEcCtD
Paliperidone—Pruritus—Epirubicin—bone cancer	0.00014	0.000665	CcSEcCtD
Paliperidone—Dizziness—Methotrexate—bone cancer	0.00014	0.000664	CcSEcCtD
Paliperidone—Diarrhoea—Epirubicin—bone cancer	0.000136	0.000643	CcSEcCtD
Paliperidone—Hypersensitivity—Doxorubicin—bone cancer	0.000135	0.000641	CcSEcCtD
Paliperidone—Vomiting—Methotrexate—bone cancer	0.000135	0.000639	CcSEcCtD
Paliperidone—Rash—Methotrexate—bone cancer	0.000134	0.000633	CcSEcCtD
Paliperidone—Dermatitis—Methotrexate—bone cancer	0.000133	0.000633	CcSEcCtD
Paliperidone—Headache—Methotrexate—bone cancer	0.000133	0.000629	CcSEcCtD
Paliperidone—Asthenia—Doxorubicin—bone cancer	0.000132	0.000624	CcSEcCtD
Paliperidone—Dizziness—Epirubicin—bone cancer	0.000131	0.000622	CcSEcCtD
Paliperidone—Pruritus—Doxorubicin—bone cancer	0.00013	0.000615	CcSEcCtD
Paliperidone—Vomiting—Epirubicin—bone cancer	0.000126	0.000598	CcSEcCtD
Paliperidone—Nausea—Methotrexate—bone cancer	0.000126	0.000597	CcSEcCtD
Paliperidone—Diarrhoea—Doxorubicin—bone cancer	0.000126	0.000595	CcSEcCtD
Paliperidone—Rash—Epirubicin—bone cancer	0.000125	0.000593	CcSEcCtD
Paliperidone—Dermatitis—Epirubicin—bone cancer	0.000125	0.000592	CcSEcCtD
Paliperidone—Headache—Epirubicin—bone cancer	0.000124	0.000589	CcSEcCtD
Paliperidone—Dizziness—Doxorubicin—bone cancer	0.000121	0.000575	CcSEcCtD
Paliperidone—Nausea—Epirubicin—bone cancer	0.000118	0.000558	CcSEcCtD
Paliperidone—Vomiting—Doxorubicin—bone cancer	0.000117	0.000553	CcSEcCtD
Paliperidone—Rash—Doxorubicin—bone cancer	0.000116	0.000548	CcSEcCtD
Paliperidone—Dermatitis—Doxorubicin—bone cancer	0.000116	0.000548	CcSEcCtD
Paliperidone—Headache—Doxorubicin—bone cancer	0.000115	0.000545	CcSEcCtD
Paliperidone—Nausea—Doxorubicin—bone cancer	0.000109	0.000517	CcSEcCtD
Paliperidone—HRH1—Signaling Pathways—GRM1—bone cancer	3.48e-05	0.00055	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—ENO2—bone cancer	3.47e-05	0.000549	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—GNA11—bone cancer	3.46e-05	0.000547	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—IL3—bone cancer	3.46e-05	0.000547	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL3—bone cancer	3.45e-05	0.000546	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL3—bone cancer	3.44e-05	0.000544	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—GNA11—bone cancer	3.41e-05	0.00054	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—GRM1—bone cancer	3.41e-05	0.00054	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL3—bone cancer	3.38e-05	0.000534	CbGpPWpGaD
Paliperidone—DRD2—Circadian rythm related genes—TP53—bone cancer	3.37e-05	0.000533	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—GNA11—bone cancer	3.36e-05	0.000532	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NDUFA12—bone cancer	3.31e-05	0.000524	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—SMO—bone cancer	3.31e-05	0.000523	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—SMO—bone cancer	3.26e-05	0.000516	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—ATF1—bone cancer	3.24e-05	0.000513	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—DHFR—bone cancer	3.22e-05	0.00051	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—ATF1—bone cancer	3.17e-05	0.000502	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—GRM1—bone cancer	3.17e-05	0.000502	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL3—bone cancer	3.16e-05	0.0005	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL3—bone cancer	3.14e-05	0.000496	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—ATF1—bone cancer	3.12e-05	0.000494	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL3—bone cancer	3.1e-05	0.00049	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL3—bone cancer	3.05e-05	0.000482	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—GNA11—bone cancer	3.03e-05	0.000479	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—GNA11—bone cancer	3.01e-05	0.000476	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—GNA11—bone cancer	2.98e-05	0.000472	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—SMO—bone cancer	2.95e-05	0.000466	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SMO—bone cancer	2.84e-05	0.00045	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SMO—bone cancer	2.83e-05	0.000448	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ENO2—bone cancer	2.82e-05	0.000446	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—ATF1—bone cancer	2.81e-05	0.000445	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—ATF1—bone cancer	2.77e-05	0.000439	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SMO—bone cancer	2.75e-05	0.000435	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NT5C3A—bone cancer	2.74e-05	0.000434	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL3—bone cancer	2.74e-05	0.000434	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—CYP3A4—bone cancer	2.73e-05	0.000432	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SMO—bone cancer	2.71e-05	0.000428	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL3—bone cancer	2.71e-05	0.000428	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TGFBR2—bone cancer	2.7e-05	0.000428	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—GNA11—bone cancer	2.69e-05	0.000426	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TGFBR2—bone cancer	2.65e-05	0.000419	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—DHFR—bone cancer	2.62e-05	0.000414	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TGFBR2—bone cancer	2.61e-05	0.000412	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—GNA11—bone cancer	2.6e-05	0.000412	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—GNA11—bone cancer	2.59e-05	0.000409	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ENO2—bone cancer	2.58e-05	0.000409	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IGF1R—bone cancer	2.54e-05	0.000402	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—GNA11—bone cancer	2.52e-05	0.000398	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—ATF1—bone cancer	2.51e-05	0.000396	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SMO—bone cancer	2.5e-05	0.000395	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IGF1R—bone cancer	2.49e-05	0.000394	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—GNA11—bone cancer	2.48e-05	0.000392	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SMO—bone cancer	2.46e-05	0.000389	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SMO—bone cancer	2.45e-05	0.000388	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IGF1R—bone cancer	2.45e-05	0.000388	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—GNA11—bone cancer	2.45e-05	0.000387	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL3—bone cancer	2.44e-05	0.000386	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—ATF1—bone cancer	2.42e-05	0.000383	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SMO—bone cancer	2.41e-05	0.000381	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—ATF1—bone cancer	2.41e-05	0.000381	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—DHFR—bone cancer	2.4e-05	0.000379	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL3—bone cancer	2.36e-05	0.000373	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL3—bone cancer	2.35e-05	0.000371	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFBR2—bone cancer	2.35e-05	0.000371	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—ATF1—bone cancer	2.34e-05	0.00037	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—GSTP1—bone cancer	2.33e-05	0.000369	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TGFBR2—bone cancer	2.31e-05	0.000366	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—ATF1—bone cancer	2.3e-05	0.000364	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—GNA11—bone cancer	2.28e-05	0.000361	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL3—bone cancer	2.28e-05	0.000361	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—GNA11—bone cancer	2.25e-05	0.000355	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL3—bone cancer	2.25e-05	0.000355	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—GNA11—bone cancer	2.24e-05	0.000355	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—GNA11—bone cancer	2.24e-05	0.000354	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SMO—bone cancer	2.24e-05	0.000354	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—CYP3A4—bone cancer	2.22e-05	0.000351	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IGF1R—bone cancer	2.21e-05	0.000349	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—GNA11—bone cancer	2.2e-05	0.000348	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IGF1R—bone cancer	2.18e-05	0.000344	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—ATF1—bone cancer	2.12e-05	0.000336	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	2.09e-05	0.000331	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—ATF1—bone cancer	2.09e-05	0.00033	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—ATF1—bone cancer	2.08e-05	0.00033	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL3—bone cancer	2.07e-05	0.000328	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—ATF1—bone cancer	2.05e-05	0.000324	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—GNA11—bone cancer	2.04e-05	0.000323	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL3—bone cancer	2.04e-05	0.000322	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL3—bone cancer	2.03e-05	0.000322	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—CYP3A4—bone cancer	2.03e-05	0.000321	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFBR2—bone cancer	2.02e-05	0.000319	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFBR2—bone cancer	2.01e-05	0.000317	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL3—bone cancer	1.99e-05	0.000316	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IGF1R—bone cancer	1.97e-05	0.000311	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	1.95e-05	0.000309	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	1.92e-05	0.000304	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—ATF1—bone cancer	1.9e-05	0.000301	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—TP53—bone cancer	1.9e-05	0.000301	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IGF1R—bone cancer	1.9e-05	0.0003	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—GSTP1—bone cancer	1.9e-05	0.0003	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IGF1R—bone cancer	1.89e-05	0.000299	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL3—bone cancer	1.85e-05	0.000293	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—KIT—bone cancer	1.85e-05	0.000292	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ENO2—bone cancer	1.84e-05	0.000291	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IGF1R—bone cancer	1.84e-05	0.00029	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IGF1R—bone cancer	1.81e-05	0.000286	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—KIT—bone cancer	1.81e-05	0.000286	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—KIT—bone cancer	1.78e-05	0.000281	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—TP53—bone cancer	1.78e-05	0.000281	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TGFBR2—bone cancer	1.77e-05	0.00028	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFBR2—bone cancer	1.74e-05	0.000276	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFBR2—bone cancer	1.74e-05	0.000275	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—GSTP1—bone cancer	1.74e-05	0.000275	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—BRAF—bone cancer	1.73e-05	0.000274	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	1.71e-05	0.00027	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—DHFR—bone cancer	1.7e-05	0.00027	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—BRAF—bone cancer	1.7e-05	0.000269	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—EGFR—bone cancer	1.68e-05	0.000266	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—BRAF—bone cancer	1.67e-05	0.000264	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IGF1R—bone cancer	1.67e-05	0.000264	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—EGFR—bone cancer	1.65e-05	0.00026	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.64e-05	0.000259	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IGF1R—bone cancer	1.64e-05	0.000259	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—EGFR—bone cancer	1.62e-05	0.000256	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IGF1R—bone cancer	1.61e-05	0.000254	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—KIT—bone cancer	1.6e-05	0.000253	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—GNA11—bone cancer	1.59e-05	0.000252	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	1.59e-05	0.000251	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—KIT—bone cancer	1.58e-05	0.00025	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—BRAF—bone cancer	1.5e-05	0.000238	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IGF1R—bone cancer	1.49e-05	0.000236	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—BRAF—bone cancer	1.48e-05	0.000235	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—EGFR—bone cancer	1.46e-05	0.000231	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MDM2—bone cancer	1.45e-05	0.00023	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CYP3A4—bone cancer	1.44e-05	0.000229	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—TP53—bone cancer	1.44e-05	0.000228	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—EGFR—bone cancer	1.44e-05	0.000228	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—KIT—bone cancer	1.43e-05	0.000226	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MDM2—bone cancer	1.42e-05	0.000225	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MDM2—bone cancer	1.4e-05	0.000221	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—KIT—bone cancer	1.38e-05	0.000218	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—KIT—bone cancer	1.37e-05	0.000217	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—BRAF—bone cancer	1.34e-05	0.000212	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—KIT—bone cancer	1.33e-05	0.000211	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—KIT—bone cancer	1.31e-05	0.000207	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—EGFR—bone cancer	1.3e-05	0.000205	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—BRAF—bone cancer	1.29e-05	0.000205	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—BRAF—bone cancer	1.29e-05	0.000204	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—JUN—bone cancer	1.26e-05	0.0002	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MDM2—bone cancer	1.26e-05	0.000199	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.25e-05	0.000198	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—BRAF—bone cancer	1.25e-05	0.000198	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.25e-05	0.000197	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MDM2—bone cancer	1.24e-05	0.000197	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—JUN—bone cancer	1.24e-05	0.000196	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—GSTP1—bone cancer	1.24e-05	0.000195	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.23e-05	0.000195	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MMP9—bone cancer	1.23e-05	0.000194	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—JUN—bone cancer	1.22e-05	0.000193	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—EGFR—bone cancer	1.21e-05	0.000192	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PTGS2—bone cancer	1.21e-05	0.000191	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—KIT—bone cancer	1.21e-05	0.000191	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MMP9—bone cancer	1.2e-05	0.00019	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ENO2—bone cancer	1.2e-05	0.00019	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.19e-05	0.000189	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—KIT—bone cancer	1.19e-05	0.000188	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—KIT—bone cancer	1.19e-05	0.000188	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MMP9—bone cancer	1.18e-05	0.000187	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—KIT—bone cancer	1.16e-05	0.000184	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—BRAF—bone cancer	1.14e-05	0.00018	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.12e-05	0.000178	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—BRAF—bone cancer	1.12e-05	0.000177	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—BRAF—bone cancer	1.12e-05	0.000176	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—DHFR—bone cancer	1.11e-05	0.000176	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—EGFR—bone cancer	1.1e-05	0.000174	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—JUN—bone cancer	1.1e-05	0.000173	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.09e-05	0.000173	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MDM2—bone cancer	1.08e-05	0.000171	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.08e-05	0.000171	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—KIT—bone cancer	1.08e-05	0.000171	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—JUN—bone cancer	1.08e-05	0.000171	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—EGFR—bone cancer	1.08e-05	0.000171	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MDM2—bone cancer	1.08e-05	0.000171	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MMP9—bone cancer	1.07e-05	0.000169	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.06e-05	0.000168	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MMP9—bone cancer	1.05e-05	0.000166	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MDM2—bone cancer	1.05e-05	0.000166	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GNA11—bone cancer	1.04e-05	0.000165	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.03e-05	0.000163	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.02e-05	0.000161	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—EGFR—bone cancer	9.93e-06	0.000157	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—EGFR—bone cancer	9.86e-06	0.000156	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTGS2—bone cancer	9.82e-06	0.000155	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—JUN—bone cancer	9.76e-06	0.000154	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—EGFR—bone cancer	9.72e-06	0.000154	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—EGFR—bone cancer	9.57e-06	0.000151	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MDM2—bone cancer	9.52e-06	0.000151	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MMP9—bone cancer	9.5e-06	0.00015	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—JUN—bone cancer	9.42e-06	0.000149	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—JUN—bone cancer	9.37e-06	0.000148	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MDM2—bone cancer	9.36e-06	0.000148	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MDM2—bone cancer	9.34e-06	0.000148	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MDM2—bone cancer	9.17e-06	0.000145	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MMP9—bone cancer	9.17e-06	0.000145	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MMP9—bone cancer	9.12e-06	0.000144	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—JUN—bone cancer	9.12e-06	0.000144	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—bone cancer	9e-06	0.000142	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—JUN—bone cancer	8.97e-06	0.000142	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MMP9—bone cancer	8.87e-06	0.00014	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MMP9—bone cancer	8.73e-06	0.000138	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—EGFR—bone cancer	8.61e-06	0.000136	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MDM2—bone cancer	8.52e-06	0.000135	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—EGFR—bone cancer	8.5e-06	0.000134	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TP53—bone cancer	8.34e-06	0.000132	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—JUN—bone cancer	8.27e-06	0.000131	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TP53—bone cancer	8.16e-06	0.000129	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—JUN—bone cancer	8.14e-06	0.000129	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—JUN—bone cancer	8.12e-06	0.000128	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GSTP1—bone cancer	8.08e-06	0.000128	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MMP9—bone cancer	8.05e-06	0.000127	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TP53—bone cancer	8.03e-06	0.000127	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—JUN—bone cancer	7.97e-06	0.000126	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MMP9—bone cancer	7.92e-06	0.000125	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MMP9—bone cancer	7.9e-06	0.000125	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MMP9—bone cancer	7.75e-06	0.000123	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—EGFR—bone cancer	7.67e-06	0.000121	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—EGFR—bone cancer	7.41e-06	0.000117	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—JUN—bone cancer	7.41e-06	0.000117	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—EGFR—bone cancer	7.37e-06	0.000117	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TP53—bone cancer	7.23e-06	0.000114	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MMP9—bone cancer	7.2e-06	0.000114	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—EGFR—bone cancer	7.17e-06	0.000113	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TP53—bone cancer	7.14e-06	0.000113	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—EGFR—bone cancer	7.05e-06	0.000112	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—EGFR—bone cancer	6.5e-06	0.000103	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TP53—bone cancer	6.44e-06	0.000102	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—bone cancer	6.4e-06	0.000101	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—EGFR—bone cancer	6.4e-06	0.000101	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—EGFR—bone cancer	6.39e-06	0.000101	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—EGFR—bone cancer	6.27e-06	9.91e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TP53—bone cancer	6.22e-06	9.84e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TP53—bone cancer	6.19e-06	9.79e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TP53—bone cancer	6.02e-06	9.52e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TP53—bone cancer	5.92e-06	9.37e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—EGFR—bone cancer	5.82e-06	9.21e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TP53—bone cancer	5.46e-06	8.64e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TP53—bone cancer	5.37e-06	8.5e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TP53—bone cancer	5.36e-06	8.48e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TP53—bone cancer	5.26e-06	8.32e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TP53—bone cancer	4.89e-06	7.73e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—bone cancer	4.18e-06	6.62e-05	CbGpPWpGaD
